DE3273278D1 - Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin - Google Patents

Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin

Info

Publication number
DE3273278D1
DE3273278D1 DE8282900970T DE3273278T DE3273278D1 DE 3273278 D1 DE3273278 D1 DE 3273278D1 DE 8282900970 T DE8282900970 T DE 8282900970T DE 3273278 T DE3273278 T DE 3273278T DE 3273278 D1 DE3273278 D1 DE 3273278D1
Authority
DE
Germany
Prior art keywords
mucopolysaccharides
heparin
biologically active
high purity
obtaining biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282900970T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Maurice Petitou
Jean Choay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Application granted granted Critical
Publication of DE3273278D1 publication Critical patent/DE3273278D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE8282900970T 1981-04-10 1982-04-09 Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin Expired DE3273278D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8107283A FR2503714B1 (fr) 1981-04-10 1981-04-10 Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
PCT/FR1982/000069 WO1982003627A1 (en) 1981-04-10 1982-04-09 Method for obtaining biologically active mucopolysaccharides of high purity,by controlled depolimerization of heparin

Publications (1)

Publication Number Publication Date
DE3273278D1 true DE3273278D1 (en) 1986-10-23

Family

ID=9257273

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282900970T Expired DE3273278D1 (en) 1981-04-10 1982-04-09 Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin

Country Status (11)

Country Link
US (1) US5019649A (de)
EP (1) EP0076279B1 (de)
JP (1) JPS58500485A (de)
AU (1) AU561167B2 (de)
CA (1) CA1213276A (de)
DE (1) DE3273278D1 (de)
FR (1) FR2503714B1 (de)
IE (1) IE52878B1 (de)
IT (1) IT1150812B (de)
SU (1) SU1531859A3 (de)
WO (1) WO1982003627A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260461A (fr) * 1984-10-18 1989-09-26 Jean-Claude Lormeau Procede de preparation de compositions de mucopolysaccharides dotes d'une activite antithrombotique elevee
FR2572080B1 (fr) * 1984-10-18 1987-06-26 Dropic Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
ES2049561B1 (es) * 1991-04-27 1994-12-16 Andromaco Lab Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
IT1282994B1 (it) * 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
BR9713141A (pt) * 1996-11-27 2000-02-08 Rhone Poulenc Rorer Pharma Composição farmcêutica processo e kit para o tratamento ou a prevenção de um quadro fisiológico asociado com um distúrbio isquêmico relacionado com trombose e um paciente, uso de quantidades farmaceuticamente efetivas de um composto com atividade anti-xa e de um composto antagonista de agregação de plaquetas, produto contendo estes compostos, e, uso destes compostos.
US5945457A (en) * 1997-10-01 1999-08-31 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science Process for preparing biologically compatible polymers and their use in medical devices
EP1188773A1 (de) * 2000-08-30 2002-03-20 Nicox S.A. Nitroderivate von Polysacchariden
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
NZ537215A (en) * 2002-06-18 2006-11-30 Glycores 2000 S Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
GB2396080B (en) * 2002-11-26 2006-03-01 Nec Technologies Improvements in standby time for dual mode mobile communication devices
EP1582531A1 (de) 2004-03-24 2005-10-05 Aventis Pharma S.A. Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2283045A1 (de) * 2008-05-20 2011-02-16 Crystal Clear Partnership Trennung von polysacchariden mittels ladungsdichtegradient
EP2526122B1 (de) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Beurteilung von heparinzubereitungen
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JP2021513593A (ja) 2018-02-14 2021-05-27 バイオロジカル イー リミテッド ダルテパリンナトリウムを調製する改善された方法
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
WO2021007429A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance

Also Published As

Publication number Publication date
SU1531859A3 (ru) 1989-12-23
AU8279482A (en) 1982-11-04
EP0076279B1 (de) 1986-09-17
EP0076279A1 (de) 1983-04-13
CA1213276A (fr) 1986-10-28
IE52878B1 (en) 1988-03-30
US5019649A (en) 1991-05-28
WO1982003627A1 (en) 1982-10-28
AU561167B2 (en) 1987-04-30
JPS58500485A (ja) 1983-03-31
IT1150812B (it) 1986-12-17
FR2503714A1 (fr) 1982-10-15
IT8220662A0 (it) 1982-04-09
IE820878L (en) 1982-10-10
FR2503714B1 (fr) 1986-11-21

Similar Documents

Publication Publication Date Title
DE3273278D1 (en) Method for obtaining biologically active mucopolysaccharides of high purity by controlled depolymerization of heparin
AR229853A1 (es) Metodo de preparar esteres interiores derivados de gangliosidos
YU43254B (en) Process for obtaining polyizocianburate by catalytic cyclotrimerisation of izocianate
JPS57145268A (en) Method of producing polymer electrode
JPS57147240A (en) Method of producing extrefine structure
DE3266045D1 (en) Process for the production of sugar ketals
IL84532A (en) Process for controlled depolymerization of glycosaminoglycans
HUT35235A (en) Process for production of optically active acetals
EP0118917A3 (en) Method for production of biologically active substances
SU1179923A3 (ru) "cпocoб пoлучehия aзoлилпehtehпpoизboдhыx"
GB2101131B (en) Method of producing guanosine by fermentation
JPS5588236A (en) Method of mounting cathode support
EP0267501A3 (en) Method for the continuous production of aliphatic compounds containing carbalkoxy groups
PL238228A1 (en) Process for preparing derivatives of delta-3 up wards-cephemo-4-carboxylic acid
SU1181542A3 (ru) "cпocoб пoлучehия пpoизboдhыx okcaдиaзoлидиha"
JPS57182974A (en) Method of producing electrode
JPS57151767A (en) Errecting method of conveyable tower
PL245707A2 (en) Method of obtaining new iuvenoides of alpha,beta non-saturated alkyl esters
PL245706A2 (en) Method of obtaining new iuvenoides of alpha,beta non-saturated alkyl esters
PL245708A2 (en) Method of obtaining new iuvenoides of alpha,beta non-saturated alkyl esters
BG34611A3 (en) Method for producing derivatives of prostaglandine
JPS5539545A (en) Method of mounting structure at high place
BG32935A1 (en) Method for obtaining of valine- lizine substance by fermeniation
BG31774A1 (en) Method for production of thermoautocathods
JPS54146417A (en) Method of mounting largeesized beam

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR